top of page

I3LUNG

INTEGRATIVE SCIENCE, INTELLIGENT DATA PLATFORM FOR INDIVIDUALIZED LUNG CANCER CARE WITH IMMUNOTHERAPY

CLINICAL TRIAL DETAILS

I3LUNG IS A EUROPEAN PROJECT FUNDED UNDER THE FRAMEWORK OF THE H2020 CALL "ENSURING ACCESS TO INNOVATIVE, SUSTAINABLE AND HIGH-QUALITY HEALTH CARE". THE PROJECT AIMS TO DEVELOP A MEDICAL DEVICE TO PREDICT IMMUNOTHERAPY EFFICACY FOR NSCLC PATIENTS THROUGH THE INTEGRATION OF MULTISOURCE DATA (REAL WORLD AND MULTI-OMICS DATA) FROM A RETROSPECTIVE AND A PROSPECTIVE PHASE. THE FINAL OBJECTIVE IS THE ESTABLISHMENT OF A WORLDWIDE DATA SHARING AND ELABORATION PLATFORM (DSEP) AND AN INDIVIDUALIZED PATIENT DECISION AID SYSTEM (iPDAS) TO SUPPORT CLINICIANS IN TREATMENT SELECTION.

COUNTRY

STATUS

TUMOR TYPE

PHASE

N

SITES

LUNG

6

2200

N/A

Spain, Greece, Italy, Israel, USA, Germany

Recruitment

TRIAL OVERVIEW

home_fondo_you_barra.jpg
Luzern_edited_edited_edited_edited_edite

PRESS RELEASE

home_fondo_you_barra.jpg

-

SCIENTIFIC IMPACT

home_fondo_you_barra.jpg

BLOG ARTICLES RELATED

home_fondo_you_barra.jpg

TRIAL SITES

home_fondo_you_barra.jpg
-
Dr. Sofia Braga
Dr. Silvi Antolín
Dr. Escrivá de Romaní
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page